Dong-E-E-Jiao Co.,Ltd. (SHE: 000423)

Market Cap	38.77B
Revenue (ttm)	5.62B
Net Income (ttm)	1.52B
Shares Out	642.46M
EPS (ttm)	2.37
PE Ratio	25.50
Forward PE	22.05
Dividend	2.29 (3.78%)
Ex-Dividend Date	Sep 10, 2024

Volume	4,910,432
Average Volume	5,129,346
Open	60.19
Previous Close	59.70
Day's Range	59.80 - 61.09
52-Week Range	44.62 - 72.91
Beta	0.69
RSI	47.55
Earnings Date	Mar 18, 2025

About Dong-E-E-Jiao

Dong-E-E-Jiao Co.,Ltd. research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods. The company was founded in 1952 and is based in Liaocheng, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1952
• Employees: 3,678
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000423

Financial Performance

In 2023, Dong-E-E-Jiao's revenue was 4.72 billion, an increase of 16.66% compared to the previous year's 4.04 billion. Earnings were 1.15 billion, an increase of 47.55%.